116 related articles for article (PubMed ID: 222150)
1. The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis.
Hirota N; Williams GM
Am J Pathol; 1979 May; 95(2):317-28. PubMed ID: 222150
[TBL] [Abstract][Full Text] [Related]
2. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
Katayama S; Ohmori T; Maeura Y; Croci T; Williams GM
J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation.
Hirota N; Williams GM
Cancer Res; 1982 Jun; 42(6):2298-309. PubMed ID: 7074612
[TBL] [Abstract][Full Text] [Related]
4. Biology of hepatocellular neoplasia in the mouse. II. Sequential enzyme histochemical analysis of BALB/c mouse liver during safrole-induced carcinogenesis.
Lipsky MM; Hinton DE; Klaunig JE; Goldblatt PJ; Trump BF
J Natl Cancer Inst; 1981 Aug; 67(2):377-92. PubMed ID: 6943376
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions.
Watanabe K; Williams GM
J Natl Cancer Inst; 1978 Nov; 61(5):1311-4. PubMed ID: 280716
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.
Maeura Y; Weisburger JH; Williams GM
Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970
[TBL] [Abstract][Full Text] [Related]
7. Nature of early appearing, carcinogen-induced liver lesions to iron accumulation.
Williams GM; Klaiber M; Parker SE; Farber E
J Natl Cancer Inst; 1976 Jul; 57(1):157-65. PubMed ID: 1003498
[TBL] [Abstract][Full Text] [Related]
8. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
LeBoeuf RA; Laishes BA; Hoekstra WG
Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
[TBL] [Abstract][Full Text] [Related]
9. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine.
Glauert HP; Beer D; Rao MS; Schwarz M; Xu YD; Goldsworthy TL; Coloma J; Pitot HC
Cancer Res; 1986 Sep; 46(9):4601-6. PubMed ID: 2873887
[TBL] [Abstract][Full Text] [Related]
10. Decreased fibronectin in rat liver altered foci and adenomas induced by N-2-fluorenylacetamide.
Maruyama H; Tanaka T; Gebhardt R; Berghem L; Williams GM
Lab Invest; 1988 Jun; 58(6):630-5. PubMed ID: 3379912
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action.
Furuya K; Maeura Y; Williams GM
Toxicol Pathol; 1984; 12(2):136-42. PubMed ID: 11478314
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
13. Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen.
Williams GM; Watanabe K
J Natl Cancer Inst; 1978 Jul; 61(1):113-21. PubMed ID: 276621
[TBL] [Abstract][Full Text] [Related]
14. Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure.
Hirota N; Williams GM
J Natl Cancer Inst; 1979 Nov; 63(5):1257-65. PubMed ID: 291752
[TBL] [Abstract][Full Text] [Related]
15. [Early histochemical markers of hepatocarcinogenesis].
Vinarchuk MP; Bykorez AI
Eksp Onkol; 1984; 6(1):11-6. PubMed ID: 6209085
[TBL] [Abstract][Full Text] [Related]
16. Enzyme histochemical phenotypes in primary hepatocellular carcinomas.
Goldfarb S; Pugh TD
Cancer Res; 1981 Jun; 41(6):2092-5. PubMed ID: 6113049
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic diversity as an early property of putative preneoplastic hepatocyte populations in liver carcinogenesis.
Ogawa K; Solt DB; Farber E
Cancer Res; 1980 Mar; 40(3):725-33. PubMed ID: 6110477
[TBL] [Abstract][Full Text] [Related]
18. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
[TBL] [Abstract][Full Text] [Related]
19. Histochemical characterization of focal hepatic lesions induced by single diethylnitrosamine treatment in infant mice.
Vesselinovitch SD; Hacker HJ; Bannasch P
Cancer Res; 1985 Jun; 45(6):2774-80. PubMed ID: 2859111
[TBL] [Abstract][Full Text] [Related]
20. Relationship of histochemically detectable altered hepatocyte foci to hepatic tumorigenesis.
Peraino C; Staffeldt EF; Carnes BA; Ludeman VA; Blomquist JA; Vesselinovitch SD
IARC Sci Publ; 1984; (56):37-55. PubMed ID: 6536601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
